Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$420K Hold
3,491
0.15% 56
2025
Q4
$367K Sell
3,491
-630
-15% -$59.1K 0.12% 67
2025
Q3
$346K Sell
4,121
-154
-4% -$12.7K 0.12% 70
2025
Q2
$338K Sell
4,275
-24
-0.6% -$1.91K 0.13% 68
2025
Q1
$386K Sell
4,299
-24
-0.6% -$2.24K 0.16% 57
2024
Q4
$430K Sell
4,323
-1,799
-29% -$185K 0.17% 46
2024
Q3
$695K Sell
6,122
-159
-3% -$18.9K 0.28% 27
2024
Q2
$778K Sell
6,281
-125
-2% -$16.1K 0.32% 26
2024
Q1
$845K Sell
6,406
-125
-2% -$15.4K 0.35% 26
2023
Q4
$712K Sell
6,531
-265
-4% -$27.5K 0.33% 24
2023
Q3
$700K Sell
6,796
-1,246
-15% -$134K 0.39% 23
2023
Q2
$928K Sell
8,042
-574
-7% -$65.2K 0.47% 23
2023
Q1
$917K Sell
8,616
-73
-0.8% -$7.88K 0.48% 24
2022
Q4
$964K Sell
8,689
-200
-2% -$20.4K 0.55% 21
2022
Q3
$765K Sell
8,889
-399
-4% -$35.6K 0.53% 19
2022
Q2
$847K Buy
9,288
+160
+2% +$14.2K 0.55% 20
2022
Q1
$749K Buy
9,128
+44
+0.5% +$3.47K 0.5% 27
2021
Q4
$696K Buy
9,084
+422
+5% +$33.6K 0.48% 28
2021
Q3
$651K Sell
8,662
-87,414
-91% -$6.65M 0.53% 27
2021
Q2
$7.47M Sell
96,076
-4,383
-4% -$326K 3.84% 6
2021
Q1
$7.39M Buy
+100,459
New +$7.41M 4.22% 4

Other funds holding MRK

Westshore Wealth's MRK Position: Q1 2026 in Review

Westshore Wealth held its Merck (MRK) position steady in Q1 2026 at 3,491 shares worth $420K. The position accounts for 0.15% of the portfolio, ranked #56.

Westshore Wealth first reported a position in MRK in Q1 2021 and has held it in 21 quarters since. The position peaked at $7.47M in Q2 2021. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Westshore Wealth held 3,491 shares of Merck worth $420K as of Q1 2026.
  • Westshore Wealth left its Merck share count unchanged in Q1 2026.
  • Merck made up 0.15% of Westshore Wealth's portfolio in Q1 2026, its #56 holding.
  • Westshore Wealth first reported a position in Merck in Q1 2021 and has held it in 21 quarters since.
  • Westshore Wealth's Merck position peaked at $7.47M in Q2 2021.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Westshore Wealth's 13F filing for Q1 2026, filed 27 May 2026.